# Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

> **NCT00140036** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 137 (—)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **PROCEDURE:** Blood draw

## Key facts

- **NCT ID:** NCT00140036
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 137 (—)
- **Last updated:** 2008-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140036, "Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00140036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*